Association of Mucin-Degrading Gut Microbiota and Dietary Patterns with Colonic Transit Time in Constipation: A Secondary Analysis of a Randomized Clinical Trial

Overview

Journal Nutrients

Date 2025 Jan 11

PMID 39796573

Authors

Xuangao Wu

Hee-Jong Yang

Myeong-Seon Ryu

Su-Jin Jung

Kwangsu Ha

Do-Yeon Jeong

Sunmin Park

Affiliations

Soon will be listed here.

Abstract

Background: The relationship between gut microbiota composition, lifestyles, and colonic transit time (CTT) remains poorly understood. This study investigated associations among gut microbiota profiles, diet, lifestyles, and CTT in individuals with subjective constipation.

Methods: We conducted a secondary analysis of data from our randomized clinical trial, examining gut microbiota composition, CTT, and dietary intake in baseline and final assessments of 94 participants with subjective constipation. Participants were categorized into normal-transit (<36 h) and slow-transit (≥36 h) groups based on CTT at baseline. Gut microbiota composition was measured using 16S rRNA sequencing, and dietary patterns were assessed through semi-quantitative food frequency questionnaires. Enterotype analysis, machine learning approaches, and metabolic modeling were employed to investigate microbiota-diet interactions. The constipated participants primarily belonged to Lachnospiraceae (ET-L).

Results: The slow-transit group showed higher alpha diversity than the normal-transit group. was abundant in the normal-transit group, while , , and were abundant in the slow-transit group, which also had a higher abundance of mucin-degrading bacteria. Metabolic modeling predicted increased N-acetyl-D-glucosamine (GlcNAc), a mucin-derived metabolite, in the slow-transit group. Network analysis identified two microbial co-abundance groups (CAG3 and CAG9) significantly associated with transit time and dietary patterns. Six mucin-degrading species showed differential correlations with GlcNAc and a plant-based diet, particularly, including rice, bread, fruits and vegetables, and fermented beans. In conclusion, an increased abundance of mucin-degrading bacteria and their predicted metabolic products were associated with delayed CTT.

Conclusion: These findings suggest dietary modulation of these bacterial populations as a potential therapeutic strategy for constipation. Moreover, our results reveal a potential immunometabolic mechanism where mucin-degrading bacteria and their metabolic interactions may influence intestinal transit, mucosal barrier function, and immune response.

References

Khanna L, Zeydan B, Kantarci O, Camilleri M . Gastrointestinal motility disorders in patients with multiple sclerosis: A single-center study. Neurogastroenterol Motil. 2022; 34(8):e14326. PMC: 9338921. DOI: 10.1111/nmo.14326. View

Park S, Li C, Wu X, Zhang T . Gut Microbiota Alterations and Their Functional Differences in Depression According to Enterotypes in Asian Individuals. Int J Mol Sci. 2023; 24(17). PMC: 10487633. DOI: 10.3390/ijms241713329. View

Riezzo G, Chimienti G, Clemente C, DAttoma B, Orlando A, Rinaldi C . Colonic Transit Time and Gut Peptides in Adult Patients with Slow and Normal Colonic Transit Constipation. Biomed Res Int. 2017; 2017:3178263. PMC: 5610809. DOI: 10.1155/2017/3178263. View

Wu X, Unno T, Kang S, Park S . A Korean-Style Balanced Diet Has a Potential Connection with Enterotype and Reduction of Metabolic Syndrome Incidence in Korean Adults. Nutrients. 2021; 13(2). PMC: 7913599. DOI: 10.3390/nu13020495. View

Pan R, Wang L, Xu X, Chen Y, Wang H, Wang G . Crosstalk between the Gut Microbiome and Colonic Motility in Chronic Constipation: Potential Mechanisms and Microbiota Modulation. Nutrients. 2022; 14(18). PMC: 9505360. DOI: 10.3390/nu14183704. View

Heirendt L, Arreckx S, Pfau T, Mendoza S, Richelle A, Heinken A . Creation and analysis of biochemical constraint-based models using the COBRA Toolbox v.3.0. Nat Protoc. 2019; 14(3):639-702. PMC: 6635304. DOI: 10.1038/s41596-018-0098-2. View

Park S, Wu X . Modulation of the Gut Microbiota in Memory Impairment and Alzheimer's Disease via the Inhibition of the Parasympathetic Nervous System. Int J Mol Sci. 2022; 23(21). PMC: 9657043. DOI: 10.3390/ijms232113574. View

Wong M, Hebbard G, Gibson P, Burgell R . Chronic constipation and abdominal pain: Independent or closely interrelated symptoms?. J Gastroenterol Hepatol. 2020; 35(8):1294-1301. DOI: 10.1111/jgh.14970. View

Every-Palmer S, Ellis P, Nowitz M, Stanley J, Grant E, Huthwaite M . The Porirua Protocol in the Treatment of Clozapine-Induced Gastrointestinal Hypomotility and Constipation: A Pre- and Post-Treatment Study. CNS Drugs. 2016; 31(1):75-85. DOI: 10.1007/s40263-016-0391-y. View

10.

Yu T, Qian D, Zheng Y, Jiang Y, Wu P, Lin L . Rectal Hyposensitivity Is Associated With a Defecatory Disorder But Not Delayed Colon Transit Time in a Functional Constipation Population. Medicine (Baltimore). 2016; 95(19):e3667. PMC: 4902539. DOI: 10.1097/MD.0000000000003667. View

11.

Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende D . Enterotypes of the human gut microbiome. Nature. 2011; 473(7346):174-80. PMC: 3728647. DOI: 10.1038/nature09944. View

12.

Sittipo P, Choi J, Lee S, Lee Y . The function of gut microbiota in immune-related neurological disorders: a review. J Neuroinflammation. 2022; 19(1):154. PMC: 9199126. DOI: 10.1186/s12974-022-02510-1. View

13.

Simpson H, Campbell B . Review article: dietary fibre-microbiota interactions. Aliment Pharmacol Ther. 2015; 42(2):158-79. PMC: 4949558. DOI: 10.1111/apt.13248. View

14.

Kim M, Lee S, Park J, Park J, Lee D, Park J . Effects of ID-HWS1000 on the Perception of Bowel Activity and Microbiome in Subjects with Functional Constipation: A Randomized, Double-Blind Placebo-Controlled Study. J Med Food. 2021; 24(8):883-893. DOI: 10.1089/jmf.2020.4746. View

15.

Cho Y, Lee Y, Shin J, Jung H, Park S, Kang S . 2022 Seoul Consensus on Clinical Practice Guidelines for Functional Constipation. J Neurogastroenterol Motil. 2023; 29(3):271-305. PMC: 10334201. DOI: 10.5056/jnm23066. View

16.

Prochazkova N, Falony G, Dragsted L, Rask Licht T, Raes J, Roager H . Advancing human gut microbiota research by considering gut transit time. Gut. 2022; 72(1):180-191. PMC: 9763197. DOI: 10.1136/gutjnl-2022-328166. View

17.

Faber W, Stolwijk-Swuste J, van Ginkel F, Nachtegaal J, Zoetendal E, Winkels R . Faecal Microbiota in Patients with Neurogenic Bowel Dysfunction and Spinal Cord Injury or Multiple Sclerosis-A Systematic Review. J Clin Med. 2021; 10(8). PMC: 8068808. DOI: 10.3390/jcm10081598. View

18.

Schmulson M, Drossman D . What Is New in Rome IV. J Neurogastroenterol Motil. 2017; 23(2):151-163. PMC: 5383110. DOI: 10.5056/jnm16214. View

19.

Ekwudo M, Gubert C, Hannan A . The microbiota-gut-brain axis in Huntington's disease: pathogenic mechanisms and therapeutic targets. FEBS J. 2024; . DOI: 10.1111/febs.17102. View

20.

Choung R, Rey E, Richard Locke 3rd G, Schleck C, Baum C, Zinsmeister A . Chronic constipation and co-morbidities: A prospective population-based nested case-control study. United European Gastroenterol J. 2016; 4(1):142-51. PMC: 4766536. DOI: 10.1177/2050640614558476. View